September 12, 2018

Tuberculosis has a much shorter incubation period than is widely thought, say Marcel A Behr and colleagues, and this has implications for prioritising research and public health strategies

August 3, 2018

Two groundbreaking studies, one in adults and the other in children, have trialed a less toxic drug than Isonaizid for latent TB and cut the treatment time from nine months to four. Read the article from the New England Journal of Medicine here: https://www.nejm.org/do...

April 26, 2018

Conference for professionals involved in all aspects of tuberculosis management: clinical care (investigation, diagnosis, treatment); occupational health; infection control; public health; policy and guideline development; immigration; laboratory science and research.

...

July 14, 2017

In this article by Dr David Griffin and A/Prof Justin Denholm they detail the influence of of infectious diseases on culture, evolution and how we, in turn, have influence them.

In 2013, the World Health Organisation declared antibiotic resistance was a threat to global...

May 16, 2017

The Pragmatic Clinical Trial for More Effective Concise and Less Toxic MDR-TB Treatment Regimen(s) (TB-PRACTECAL) is a multi-center, open label, multi-arm, randomized, controlled phase II-III trial. TB-PRACTECAL, a Médecins Sans Frontières (MSF) sponsored clinical tria...

March 14, 2017

ACTnet will officially launch at the TSANZ  annual scientific meeting on Monday 27th of March at the end of the special interest group meeting 'Advances in Tuberculosis' 8.30-10.30am by Dr Greg Fox.

The SIG meeting will be held in the Royal Theatre.

Attendee's...

Please reload

Archive
Please reload

Search By Tags
Please reload

Follow Us
  • Twitter Basic Square
Social media

Get in touch via twitter  @actnet_tb 

  • Facebook Social Icon
  • Twitter Social Icon
  • Google+ Social Icon
  • YouTube Social  Icon
  • Pinterest Social Icon
  • Instagram Social Icon